Peer support to maintain psychological wellbeing in people with advanced cancer: findings from a feasibility study for a randomised controlled trial.
Cancer
Feasibility study
Palliative care
Peer support
Journal
BMC palliative care
ISSN: 1472-684X
Titre abrégé: BMC Palliat Care
Pays: England
ID NLM: 101088685
Informations de publication
Date de publication:
17 Aug 2020
17 Aug 2020
Historique:
received:
04
12
2019
accepted:
07
08
2020
entrez:
19
8
2020
pubmed:
19
8
2020
medline:
28
4
2021
Statut:
epublish
Résumé
Advanced cancer affects people's lives, often causing stress, anxiety and depression. Peer mentor interventions are used to address psychosocial concerns, but their outcomes and effect are not known. Our objective was to determine the feasibility of delivering and investigating a novel peer mentor intervention to promote and maintain psychological wellbeing in people with advanced cancer. A mixed methods design incorporating a two-armed controlled trial (random allocation ratio 1:1) of a proactive peer mentor intervention plus usual care, vs. usual care alone, and a qualitative process evaluation. Peer mentors were recruited, trained, and matched with people with advanced cancer. Quantitative data assessed quality of life, coping styles, depression, social support and use of healthcare and other supports. Qualitative interviews probed experiences of the study and intervention. Peer mentor training and numbers (n = 12) met feasibility targets. Patient participants (n = 12, from 181 eligible who received an information pack) were not recruited to feasibility targets. Those who entered the study demonstrated that intervention delivery and data collection were feasible. Outcome data must be treated with extreme caution due to small numbers, but indicate that the intervention may have a positive effect on quality of life. Peer mentor interventions are worthy of further study and researchers can learn from these feasibility data in planning participant recruitment and data collection strategies. Pragmatic trials, where the effectiveness of an intervention is tested in real-world routine practice, may be most appropriate. Peer mentor interventions may have merit in enabling survivors with advanced cancer cope with their disease. The trial was prospectively registered 13.6.2016: ISRCTN10276684 .
Sections du résumé
BACKGROUND
BACKGROUND
Advanced cancer affects people's lives, often causing stress, anxiety and depression. Peer mentor interventions are used to address psychosocial concerns, but their outcomes and effect are not known. Our objective was to determine the feasibility of delivering and investigating a novel peer mentor intervention to promote and maintain psychological wellbeing in people with advanced cancer.
METHODS
METHODS
A mixed methods design incorporating a two-armed controlled trial (random allocation ratio 1:1) of a proactive peer mentor intervention plus usual care, vs. usual care alone, and a qualitative process evaluation. Peer mentors were recruited, trained, and matched with people with advanced cancer. Quantitative data assessed quality of life, coping styles, depression, social support and use of healthcare and other supports. Qualitative interviews probed experiences of the study and intervention.
RESULTS
RESULTS
Peer mentor training and numbers (n = 12) met feasibility targets. Patient participants (n = 12, from 181 eligible who received an information pack) were not recruited to feasibility targets. Those who entered the study demonstrated that intervention delivery and data collection were feasible. Outcome data must be treated with extreme caution due to small numbers, but indicate that the intervention may have a positive effect on quality of life.
CONCLUSIONS
CONCLUSIONS
Peer mentor interventions are worthy of further study and researchers can learn from these feasibility data in planning participant recruitment and data collection strategies. Pragmatic trials, where the effectiveness of an intervention is tested in real-world routine practice, may be most appropriate. Peer mentor interventions may have merit in enabling survivors with advanced cancer cope with their disease.
TRIAL REGISTRATION
BACKGROUND
The trial was prospectively registered 13.6.2016: ISRCTN10276684 .
Identifiants
pubmed: 32807157
doi: 10.1186/s12904-020-00631-z
pii: 10.1186/s12904-020-00631-z
pmc: PMC7433175
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
129Subventions
Organisme : Department of Health
ID : PB-PG-0614-34070
Pays : United Kingdom
Organisme : Research for Patient Benefit Programme
ID : PB-PG-0614-34070
Références
QJM. 2013 Nov;106(11):995-1001
pubmed: 23737506
Palliat Med. 2011 Dec;25(8):741-7
pubmed: 21993806
PLoS One. 2017 Jan 20;12(1):e0169071
pubmed: 28107352
J Cancer Surviv. 2008 Mar;2(1):45-52
pubmed: 18648986
Cancer Treat Rev. 2017 May;56:16-27
pubmed: 28453966
Clin Infect Dis. 2016 Sep 1;63(5):678-686
pubmed: 27217266
Patient Educ Couns. 2008 Jan;70(1):10-24
pubmed: 17904782
Palliat Med. 2016 Mar;30(3):200-11
pubmed: 26269324
J Pain Symptom Manage. 2013 Sep;46(3):395-405
pubmed: 23245452
J Clin Epidemiol. 2012 Oct;65(10):1107-16
pubmed: 22818947
QJM. 2013 Dec;106(12):1071-5
pubmed: 24082152
Curr Opin Support Palliat Care. 2018 Sep;12(3):308-322
pubmed: 29979318
Int J Nurs Stud. 2003 Mar;40(3):321-32
pubmed: 12605954
J Pain Symptom Manage. 2018 Nov;56(5):689-698
pubmed: 30096440
Health Expect. 2012 Mar;15(1):49-62
pubmed: 21281412
Int J Behav Med. 1997;4(1):92-100
pubmed: 16250744
BMC Public Health. 2013 Aug 23;13:773
pubmed: 23968220
J Cancer Educ. 2020 Jan 28;:
pubmed: 31994006
Support Care Cancer. 2019 Jan;27(1):97-108
pubmed: 30293093
Support Care Cancer. 2010 Sep;18(9):1123-36
pubmed: 20336326
Qual Life Res. 2004 Mar;13(2):299-310
pubmed: 15085902
BMJ. 2016 Oct 24;355:i5239
pubmed: 27777223
J Health Serv Res Policy. 1996 Oct;1(4):194-7
pubmed: 10180870
BMJ Glob Health. 2018 Jan 6;3(Suppl 1):e000609
pubmed: 29379649
BMJ. 2008 Oct 31;337:a1864
pubmed: 18977792
Eur J Cancer. 2006 Jan;42(1):55-64
pubmed: 16162404
Br J Psychiatry. 2010 Feb;196(2):96-101
pubmed: 20118451
Patient Educ Couns. 2008 Mar;70(3):315-37
pubmed: 18191527
Palliat Med. 2018 May;32(5):990-1009
pubmed: 29485314
Psychooncology. 2015 Sep;24(9):1080-7
pubmed: 25389107
BMC Psychiatry. 2012 Nov 09;12:196
pubmed: 23140497
BMC Med Res Methodol. 2013 Aug 20;13:104
pubmed: 23961782
Asia Pac J Clin Oncol. 2016 Mar;12(1):e38-46
pubmed: 23551493
BMC Med. 2016 Dec 9;14(1):203
pubmed: 27931214
BMC Med Res Methodol. 2006 Nov 08;6:54
pubmed: 17092344
BMJ. 2018 Nov 28;363:k4738
pubmed: 30487232
J Pain Symptom Manage. 2017 Dec;54(6):889-897
pubmed: 28803091
BMJ Open. 2017 Apr 26;7(4):e014304
pubmed: 28446525
PLoS One. 2018 Apr 23;13(4):e0195951
pubmed: 29684043
Palliat Med. 2002 Mar;16(2):81-97
pubmed: 11969152
J Cancer Educ. 2014 Mar;29(1):91-8
pubmed: 24078346
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
BMJ. 2008 Nov 11;337:a2390
pubmed: 19001484
Lancet Oncol. 2011 Feb;12(2):160-74
pubmed: 21251875
Paediatr Child Health. 2017 Oct;22(7):387-390
pubmed: 29479254
Urology. 2002 Jan;59(1):103-9
pubmed: 11796290
Complement Ther Clin Pract. 2018 Feb;30:68-78
pubmed: 29389483
Psychooncology. 2018 Jan;27(1):229-235
pubmed: 28695612